Dravo Bay LLC Bio N Tech Se Transaction History
Dravo Bay LLC
- $174 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$809 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$422 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$401 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$188 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$179 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...